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Abstract
Background: Buruli ulcer (BU) is a chronic, indolent necrotizing disease of the skin and underlying tissues caused by
Mycobacterium ulcerans, which may result in functional incapacity. In 2002, Me ´decins Sans Frontie `res (MSF) opened a BU
programme in Akonolinga Hospital, Cameroon, offering antibiotic treatment, surgery and general medical care. Six hundred
patients have been treated in the project to date. However, due to the nature of the disease and its stigmatization,
determining the exact prevalence and burden of disease is difficult and current estimates may not reflect the magnitude of
the problem. The objectives of this survey were to estimate the prevalence of BU in the health district of Akonolinga,
describe the geographic extension of the highly endemic area within the health district, and determine the programme
coverage and its geographical distribution.
Methodology/Principal Findings: We conducted a cross-sectional population survey using centric systematic area sampling
(CSAS). A 15615 km grid (quadrats of 225 km
2) was overlaid on a map of Akonolinga district with its position chosen to
maximize the area covered by the survey. Quadrats were selected if more than 50% of the quadrat was inside of the health
district. The chiefdom located closest to the centre of each quadrat was selected and Buruli cases were identified using an
active case finding strategy (the sensitivity of the strategy was estimated by capture-recapture). WHO-case definitions were
used for nodules, plaque, ulcer, oedema and sequelae. Out of a total population of 103,000 inhabitants, 26,679 were
surveyed within the twenty quadrats. Sensitivity of the case finding strategy was estimated to be 84% (95%CI 54–97%). The
overall prevalence was 0.47% (n=105) for all cases including sequelae and 0.25% (n=56) for active stages of the disease.
Five quadrats had a high prevalence of .0.6% to 0.9%, 5 a prevalence .0.3% to 0.6% and 10 quadrats ,0.3%. The quadrats
with the high prevalence were situated along the rivers Nyong and Mfoumou. Overall coverage of the project was 18% (12–
27%) for all cases and 16% (9–18%) for active cases, but was limited to the quadrats neighbouring Akonolinga Hospital.
Conclusions/Significance: Prevalence was highest in the area neighbouring the Nyong River. Coverage was limited to the
area close to the hospital and efforts have to be made to increase access to care in the high prevalence areas. Use of the
CSAS method was particularly useful for project planning and to identify priority areas of intervention. An added benefit of
the method is that the survey procedure incorporated an awareness campaign, providing information about the disease
and treatment to the population.
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Introduction
Buruli ulcer (BU) is a neglected tropical disease caused by
Mycobacterium ulcerans, belonging to the same family of organisms
causing tuberculosis and leprosy. Awareness about the public
health importance of the disease was raised in 1998 by the World
Health Organisation (WHO) initiative [1].
BU affects predominantly children between 5 and 15 years. The
clinical lesions of BU generally start as a painless subcutaneous
nodule that secondarily ulcerates, presenting characteristic under-
mined edges. M. ulcerans produces a toxin, mycolactone, which
destroys the skin and the subcutaneous tissues, induces necrosis
and ulcerations. Ulcers are chronic, indolent and mainly located
on the legs and arms. Some patients develop osteomyelitis and
joint lesions. Natural evolution of the disease may lead to
spontaneous healing but in the absence of early detection and
appropriate treatment, the disease can extend, disseminate and
leave functional incapacity [2]. Clinical diagnosis for the ulcerative
form is straightforward for trained medical staff, although more
difficult for the nodules, plaque and oedematous forms [3].
Based on some observational studies, the WHO recently
recommended the use of the combination of Rifampicin/
Streptomycin for BU treatment [4]. However, surgery remains
important for BU treatment. In the early stages of infection,
surgery is curative and highly cost effective, since it requires a
simple excision followed by an immediate closure. In the disease’s
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stop the infection and prevent recurrence or relapse at the same
site. This is followed by skin grafting and requires long hospital
stays [5]. As long as the mode of transmission is not understood,
and in the absence of an effective vaccine, control strategies
promoting early detection and treatment have achieved the best
results in limiting morbidity and costs associated with the disease
[6].
Although BU has been reported in 30 countries in Africa, Asia
and the Western Pacific [7], determining the exact prevalence and
burden of disease is difficult and current estimates may not reflect
the magnitude of the problem. These difficulties include un-
diagnosed cases due to fears of stigmatization, little knowledge of
the disease among both the population and health workers and the
variability in clinical presentation of the disease. Further, BU
occurs primarily in remote rural areas where the population may
have limited access to health care and the disease is not notifiable
in many countries [8]. Prevalence estimates are needed for
appropriate resource allocation and to plan control strategies.
In Cameroon, BU cases have been reported in 6 provinces,
Adamaoua, Central, South, South-East, East and Extreme North.
A national survey identified Akonolinga as a health district of high
prevalence [9]. BU endemic areas are located along the Nyong
River (Ayos and Akonolinga health districts) with an estimated
prevalence of 0.44% in 2001 [10]. Recently, several risk factors
were identified including swamp wading, wearing shorts, lower-
body clothing while farming, living near cocoa plantation or wood
and using adhesive bandages when hurt [11]. In 2002, Me ´decins
sans Frontie `res (MSF) opened a BU project in Akonolinga District,
one of the 135 health districts of Cameroon, in collaboration with
the local and national health authorities of Cameroon. The project
was set up in Akonolinga Hospital, with a passive case detection
strategy. To date, 600 BU patients have been treated in the MSF
project, which offers antibiotic treatment, surgery and general
medical care. Most patients present late to the Akonolinga
Hospital, presenting mainly with ulcerative lesion (about 80%)
and advanced stages of BU. A study conducted in 2004 in the
district described stigmatisation of BU patients and reported that
traditional healers were the first source of treatment [12].
In March 2007 we conducted a cross-sectional survey to: 1)
estimate the prevalence of BU in the target population of the
project; 2) to estimate the proportion of BU cases visiting the MSF
project at least once (coverage); and 3) to estimate the proportion
of patients visiting another service provider such as a traditional
healer or peripheral health centre at least once (health seeking
behaviour). We also aimed to describe the spatial distribution of
the prevalence as well as that of health seeking behaviour to help
target the most affected areas and to address access problems for
certain communities.
Methods
Study Site
Akonolinga health-district is a 1-hour drive from Yaounde ´i n
the department of Nyong and Mfoumou. The health district is at
its longest distance approximately 70 km east to west, and 100 km
north to south. It has a surface of approximately 4500 km2. The
district hospital is in Akonolinga, situated in the geographic centre
of the district. The Akonolinga health-district has a total
population of 103,000 inhabitants.
Study Design
We performed a cross-sectional survey using centric systematic
area sampling (CSAS). CSAS has been used successfully in past
research in malnutrition and other low prevalence diseases [13]. It
is particularly well suited to situations where the disease is visible,
of low prevalence and where geographic distribution of prevalence
and program coverage is of interest.
A1 5 615 km grid (quadrats of 225 km
2) was overlaid on a map
of Akonolinga district with its position chosen to maximize the
area covered by the survey. Quadrats were selected if more than
50% of the quadrat was inside of the health district, resulting in 20
quadrats identified.
Our sampling unit was the che `ferie (chiefdom), the lowest
administrative unit in Cameroon. The che `ferie located closest to
the centre of each quadrat was selected. Che `feries may be
comprised of one to several villages. If the total population of the
selected che `ferie was below 1000 persons, the next closest che `ferie
was also included to obtain our required sample size as discussed
below. Population information for the selected che `feries was
obtained from the chief of each che `ferie and crosschecked with the
Chief’s Office, Department of Nyong and Mfoumou and the
Department of Development that compared the figures with the
2005 census. All inhabitants of the che `feries were invited to
participate in the study.
To estimate an expected prevalence of all forms of BU of 0.6%
with 0.1% precision, our required sample size was18,742
inhabitants. Using the same prevalence estimate, and assuming
50% program coverage with 10% precision, our required sample
size was 83 cases, corresponding to a population of 13,900 persons.
We used the WHO case-definition of BU [2], limiting the
definition of an active case to nodule, plaque, oedema and ulcer
(Table 1). We did not include the WHO papula stages because of
the very low specificity of the clinical signs and considering that
this clinical form is quite rare in West Africa. Sequelae were
defined as having a history of BU and complications resulting
directly from the lesion (e.g., restricted limb movement, amputa-
tion, organ loss). Disfiguring stellar scars not associated with
disabilities were not considered as sequelae.
Our secondary endpoints concerned program coverage, specif-
ically attending the BU hospital, the Ministry of Health (MOH)
Health Centre or a traditional healer for BU treatment. We
Author Summary
As long as there is no strategy to prevent Buruli ulcer, the
early detection and treatment of cases remains the most
promising control strategy. Buruli ulcer is most common in
remote rural areas where people have little contact with
health structures. Information on the number of existing
cases in the population and where they go to seek
treatment is important for project planning and evalua-
tion. Health structure based surveillance systems cannot
provide this information, and previous prevalence surveys
did not provide information on spatial distribution and
coverage. We did a survey using centric systematic area
sampling in a Health District in Cameroon to estimate
prevalence and project coverage. We found the method
was easy to use and very useful for project planning. It
identified priority areas with relatively high prevalence and
low coverage and provided an estimate of the number of
existing cases in the population of the health district. The
active case finding component of the method used served
as an awareness campaign and was an integrated part of
the project, creating a network of health delegates trained
on Buruli ulcer.
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treatment for the presenting BU lesion.
Field Procedures
BU cases were identified using a combined active case finding
strategy. In a preparation phase, all selected che `feries were visited.
A meeting was held in Akonolinga with the chiefs of all the
selected villages, to explain the survey. Health delegates from the
MOH network received two days of training in survey procedures.
In each village, the survey started with a meeting, to explain the
objectives of the survey and the clinical signs of BU. Villagers were
informed that, on a specified day, a medical team would come and
screen every suspect case of BU at a central location. Traditional
healers were contacted and informed and asked to send their
patients to this central screening location. They were assured that
there would be no attempt to take patients away from them.
Special attention was paid to ensure that key informants (women
leaders, traditional healers, village leaders) understood the
objectives of the survey and the different clinical forms of BU,
making every effort to use non-medical terms. During the meeting,
the villagers were also informed about the second part of the active
case finding strategy which consisted of house to house visits by
health delegates, identifying suspect cases in the household and
informing them personally about the central screening. The chief
introduced the health delegates identified for this task to the
community.
Health delegates had at least one week between the village
meeting and the day of the central screening to perform the house
to house visits. They provided information about the survey and
identified suspected BU cases. They discussed the fear of
stigmatisation with suspected cases, and arranged individual
meetings with the medical team for suspected patients who did
not want to come to the central meeting point, or arranged for
transport for disabled patients. They asked for oral consent of
suspected cases identified for possible inclusion in the survey. They
also collected information on patients who were living in a
household but at the time of the survey were admitted at
Akonolinga Hospital. These patients were interviewed at the
hospital.
A team comprised of one doctor/nurse experienced in BU, one
medical assistant and one interviewer performed the consultations
and interviews at the central screening location. The lesion was
inspected, measured and categorized according to clinical criteria
using the clinical case definitions. A short standardized question-
naire was administered, inquiring when the first symptoms started
and where the patients were seeking care. When relevant, patients
were asked why they did not go to Akonolinga Hospital. Regular
field visits were made to supervise the patient interviews and
questionnaire procedures.
Statistical Analysis
For the statistical analyses, CSAS was treated as a random
sample [14]. Prevalence (P) was computed as (detected cases/
population)*(100/sensitivity (%) of the case finding strategy)*100.
Coverage was calculated as the number of detected cases who had
visited the healthcare provider/total number of detected cases.
Capture/recapture was used to estimate the sensitivity of the case
finding strategy. The estimated total number of patients (N) was
N={[(M+1)(C+1)]/(R+1)}21 [15] with M representing the cases
detected by central location screening, C the cases detected by the
combined active case finding strategy, and R cases that were
detected by both strategies. Since it is impossible to have fractions
of cases, the estimated value for N was rounded up to the nearest
whole number [16,17]. Sensitivity of the combined case finding
strategy was computed as S=C/N.
Qualitative Analysis
Answers to open questions in the questionnaire about health
care seeking behaviour were noted word-for-word and coded in a
content analysis. Resulting codes were grouped in categories.
Ethical Considerations
Authorization to conduct the survey was granted by the
Ministry of Health, Department of Research. Approval from the
National Ethical Committee (012/CNE/MP/07) and from the
Ethical Committee of MSF was obtained. Informed written
consent was asked from all ulcer patients who participated in the
survey.
Results
Out of a total population of 103,000 inhabitants, 26,679 lived
in the sampled che `feries. A total of 105 BU cases were
identified. The age of the cases ranged from 2 to 75 years. The
median age for active cases was 15.5 years (Interquartile range
(IQR) 11–34 years) and 16 years for patients with sequelae (IQR
13–25). The female/male ratiobwas 0.8 (46/59) for all cases. Of
the 105 cases identified, 49 (46.7%) presented with a sequelae
and 56 (53.3%) were active cases. A total of 93 cases (88.6%)
presented with one lesion and 12 cases (11.4%) with two lesions.
The location of the first lesion was predominantly on the legs,
68 cases(64.8%).
Of the 56 active cases, the major or first lesion was an ulcer in
48 cases(85.7%), an oedema in 4 cases(7.1%) and a nodule in 4
cases (7.1%). The median diameter of ulcers was of 4 cm (IQR 2–
7 cm) meaning that half of the ulcer cases would have been
classified as category 1 or early lesions according to the new WHO
categories. The median delay since beginning of the first BU
symptoms for active cases was 12 weeks (IQR 3–30).
Prevalence
The overall prevalence of all BU cases was 4.7/1000 (95%CI:
4.1–7.3/1000) and the prevalence for active BU cases was
estimated as 2.5/1000 (95%CI: 2.2–3.9/1000). Prevalence
estimates per quadrat were categorized as low, middle or high.
For active cases, categories were: 0 to 2 cases/1000; .2/1000 to 4
Table 1. Clinical case definitions of active cases.
Nodule Firm at palpation, painless, diameter at least 1 cm, in the subcutaneous tissue adherent to the skin
Plaque A large painless swelling of at least 2 cm, with clearly marked borders, carton-like at palpation
Oedema A large diffuse non-pitting swelling, with clearly marked borders
Ulcer Painless, cutaneous lesion with a necrotic centre and undermined edges
doi:10.1371/journal.pntd.0000466.t001
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categories were: 0 to 3 cases/1000; .3/1000 to 6 /1000; and .6/
1000 to 9/1000 inhabitants (Figure 2). The spatial distribution of
prevalence estimates per quadrat showed that quadrats with high
estimates were predominantly situated along the Nyong and
Mfoumou rivers (Figures 1 and 2).
Program Coverage
Of the 105 cases identified, 19 cases had visited Akonolinga
Hospital resulting in an estimated coverage for the MSF BU
project of 18% (95%CI 11–27%). A total of 23 patients visited the
health centre at least once, leading to an estimated coverage of the
peripheral MoH health centres of 22% (95%CI 15–31%). A high
Figure 1. Map of Akonolinga Health district, prevalence of active BU cases, March 2007.
doi:10.1371/journal.pntd.0000466.g001
Figure 2. Map of Akonolinga Health district, prevalence of all BU cases, March 2007.
doi:10.1371/journal.pntd.0000466.g002
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once, yielding a coverage of 73% (95%CI 64–81%).
Coverage estimates per quadrat were classified in 5 categories.
Coverage for all BU cases for the MSF project was above 60% in
the quadrat including the Akonolinga Hospital; Health centre
coverage was above 60% in 3 quadrats; and above 60% in 17
quadrats for traditional healers coverage (Table 2). The same
trend in coverage was seen for active BU cases. Coverage of the
MSF project was 16% (95%CI 9–28%) and of the peripheral
MOH Health centres was 23% (95%CI 14–36%), while coverage
of traditional practitioners was 61% (95%CI 48–73%).
The geographic distributions of the coverage of the three health
care providers (Hospital, health centres and traditional healers) are
shown in Figure 3. The quadrate including the hospital had the
highest hospital coverage and the lowest traditional healer
coverage.
Sensitivity of Case Finding
We visited three che `feries (2700 inhabitants) in the health
district that were not part of the survey sample to estimate the
sensitivity of the case finding strategy. We found 8 cases by central
location screening (M), 11 cases by combined active case finding
strategy (C), and 7 cases were found by both strategies (R). The
total estimated number of cases was 13. The sensitivity of the
active case finding method was 84.6% (95% CI: 53.7–97.3%).
Reasons for Not Going to the Hospital
Out of 86 patients who did not present to Akonolinga Hospital,
79 answered the question on motive for non-attendance. In the
content analysis, a total of 87 reasons were coded. Twenty-five
(31.6%) patients answered that they did not have enough money;
14 (17.7%) that the hospital was too far; 22 (27.8%) mentioned a
lack of information; 13 were not aware of the services offered at
Table 2. Number of quadrats with coverage estimate for all BU cases and active BU cases, Akonolinga, Cameroon, March 2007.
Coverage
estimates % All BU cases Active BU cases*
Akonolinga
Hospital
Health
centres
Traditional
practitioners
Akonolinga
Hospital
Health
centres
Traditional
practitioners
[0–20] 12 8 1 13 11 2
[20–40] 6 6 0 2 1 0
[40–60] 1 3 2 2 1 4
[60–80] 1 0 7 1 2 6
[80–100] 0 3 10 0 3 6
*2 Quadrats did not have active cases.
doi:10.1371/journal.pntd.0000466.t002
Figure 3. Map of Akonolinga Health district, coverage of the BU project, traditional healers and health centres, for active BU cases,
March 2007.
doi:10.1371/journal.pntd.0000466.g003
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said that they did not want surgery.
Discussion
Prevalence and mapping of Buruli ulcer is one of the priority
areas identified by the research subgroup at the 5th WHO
Advisory Group Meeting on Buruli Ulcer held in March 2002.
Studies, like the one reported here, were noted as most likely to
provide immediate direct benefit to Buruli ulcer patients in the
medium term. The use of CSAS allowed for the identification of
areas with relatively high prevalence and low coverage. An added
benefit of the method is that the survey procedure also served as an
awareness campaign, providing information about the disease and
treatment to the population.
As previously described (4, 8), cases identified were predomi-
nantly younger than 15 years and more often male than female.
This underlines once again the importance of BU as a potentially
severe disabling disease that occurs at a young age. Most of the
active cases (85.7%) identified presented with an ulcerative form of
the disease, corresponding to what is seen at admission to the
hospital (81.6%).
The overall prevalence was 0.47% (n=105) for all BU cases
including sequelae and 0.25% (n=56) for active stages of the
disease in accordance with a survey conducted previously in the
region (8). Because of the lack of comparable survey in other
regions it is difficult to compare our results to other estimates [18],
but they corresponds to the estimated prevalence of tuberculosis in
2006 in Cameroon [19] and are slightly higher than the 6000 cases
detected in a national survey in Ghana in 1999 [8]. Quadrats with
higher prevalence were situated along the Nyong and Mfoumou
Rivers confirming reports that cases are often found near slow
moving water.
The quadrat of the area of the hospital had a high prevalence of
BU, but the two other high prevalence areas were at a distance of
25 to 40 km from the hospital in the southwest of the health
district.
Overall coverage of the MSF project was disappointing with
18% (12–27%) for all cases and 16% (9–18%) for active cases and
was limited to quadrats neighbouring Akonolinga hospital. If we
combine the geographical distribution of prevalence and coverage,
we can identify the southwest of the health district as a priority
area for intervention with high prevalence and low project
coverage estimates. The coverage of the MOH health centres
(22%) was slightly higher than the coverage of the hospital. It is
important to note that this was also the case in some of the areas
furthest from hospital and indicates the importance of decentral-
ization and a functioning referral system. The high proportion of
patients having visited the traditional healers, particularly in
remote areas, underlines the importance of reviewing possibilities
to integrate traditional healers in the project approach.
Buruli ulcer represents a financial burden for the patients and
the health structures [20] Reasons given for not choosing the
hospital as a health care provider were mainly financial and
distance to the hospital. Lack of information about the existence of
the project was also mentioned. Information on free treatment and
decentralization towards health centres of diagnosis, antibiotic
treatment and daily dressing, could remove barriers and rapidly
improve coverage, especially when first targeting areas with high
prevalence and low coverage.
A total of 15% of patients who had not gone to the hospital said
it was because they did not want surgery. Providing information
on the multidisciplinary combination of BU treatments (antibiot-
ics, dressing, surgery, physiotherapy and nutrition) and giving
patients the possibility to make an informed choice on which part
of the treatment to accept might reduce fears and improve
collaboration with traditional healers.
The quadrat including Akonolinga town presented a high
prevalence and a high coverage. Since this quadrat had
presumably a high population density, the overall prevalence
and coverage for the health district might be slightly underesti-
mated [11]. Population estimates of the sampled che `feries were
obtained from the chiefs of the villages and confirmed by the
prefecture and did not vary largely among the quadrats. Although
all chiefs and all health delegates completed the same training,
trust among health delegates, chiefs and villagers is a social reality
that might influence the sensitivity of case finding and might vary
largely. This will remain a weakness of active case finding
strategies that are based on existing social networks.
In conclusion, this method was easy to use. It provided estimates
of overall prevalence and coverage and identified high prevalence
and low coverage areas for intervention. In addition the survey can
be considered an information and awareness campaign in itself
that also allowed to create a network of health delegates trained on
Buruli ulcer that might refer patients in future.
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